Why Tonka Beans Are Banned in the US (But Beloved Everywhere Else)

A single ingredient sits in the same federal regulatory category as lead-capped wine bottles and carcinogenic sassafras oil — yet French pastry chefs grate it over crème brûlée without a second thought, and roughly a third of the world’s fine fragrances are built on its scent. The tonka bean has been banned from American food since 1954, and the science behind that ban tells a more complicated story than “it’s toxic” or “it’s harmless.”

What the evidence supports: Tonka beans contain high concentrations of coumarin (roughly 1–4% by weight), and coumarin causes liver damage in animals and, in a susceptible subgroup of people, at sustained high doses. The FDA’s 1954 ban is a real, enforceable food-additive prohibition.

What’s overstated or unsupported: The idea that a grating of tonka over a dessert poses meaningful danger. Realistic culinary exposure falls far below the tolerable daily intake European regulators set after reviewing the human data, and documented coumarin liver injury comes almost entirely from medicinal doses, not food.

⚕️ LyfeiQ Score: 6/10 — The compound is genuinely hepatotoxic at high doses, but the blanket US food ban is more a relic of 1950s regulatory caution than a match for the actual risk of an occasional pinch.

What Does the Research Actually Show About Coumarin?

Coumarin is a naturally occurring plant compound, not a synthetic contaminant. It was first isolated from the tonka bean in 1820 — the bean’s South American name, coumarou, is where the molecule got its name. It smells of fresh-cut hay, vanilla, and warm almond, and it shows up naturally in cassia cinnamon, sweet woodruff, bison grass, and trace amounts in cherries, strawberries, and green tea.

The toxicology that drove the ban came from animal studies. High oral doses produced liver damage and tumors in dogs and rats, which is what the FDA acted on in 1954. But the modern picture is more nuanced. A 2010 review of the human data on coumarin toxicity published in Molecular Nutrition & Food Research found that much of the rodent liver toxicity runs through a metabolic pathway humans rely on far less. That review concluded the species difference is real — people generally detoxify coumarin more efficiently than rats do, mostly by converting it to 7-hydroxycoumarin and excreting it.

That same review flagged the catch, though: a subgroup of people appears unusually sensitive to coumarin’s effects on the liver, and the reason isn’t fully understood. A gene-expression comparison of rat and human liver cells confirmed the overall responsiveness to coumarin was much higher in rats than in humans. And a pharmacogenomics analysis of coumarin-induced hepatotoxicity pointed to people who poorly metabolize coumarin via the CYP2A6 enzyme — they shunt it into a more cytotoxic pathway, which may explain the rare human cases. Those human cases came from patients given coumarin as a drug for conditions like lymphedema, at doses dwarfing anything you’d get from food.

How Much Coumarin Are We Actually Talking About?

The threshold that matters is the tolerable daily intake. After re-examining the evidence, the European Food Safety Authority set a TDI for coumarin of 0.1 mg per kilogram of body weight per day — a level confirmed by the human-data review noted above. For a 70 kg (155 lb) adult, that’s about 7 mg of coumarin a day, every day, before you’d cross the line regulators consider prudent.

Now the arithmetic. Tonka beans are 1–4% coumarin by weight, but a single dessert uses a fraction of one bean — a light grating, often a tenth of a gram or less of bean across multiple servings. Compare that to the more common dietary source: cassia cinnamon, the supermarket-default cinnamon, runs up to about 1% coumarin. A human crossover study on coumarin bioavailability from cinnamon found coumarin in cinnamon is absorbed about as readily as the isolated compound, so the spice on your oatmeal counts. The researchers concluded heavy cassia-cinnamon consumers can reach the TDI — which means a daily cinnamon habit is a more realistic route to high coumarin intake than the occasional tonka-spiked dessert most people will never eat.

One persistent myth worth killing: coumarin is not warfarin. They share a chemical family name, but the simple coumarin in tonka beans and cinnamon does not thin your blood. A cinnamon roll won’t interact with your clotting the way the prescription anticoagulant does.

How Do Regulators, Chefs, and the Public See It Differently?

Regulatory and toxicological consensus. The US position is codified at 21 CFR 189.130: any food containing added coumarin, “as such or as a constituent of tonka beans or tonka extract,” is deemed adulterated, tracing to a Federal Register order from March 5, 1954. The word doing the heavy lifting is added. That’s why cassia cinnamon — which naturally carries coumarin — stays legal: nobody is adding the coumarin, it’s intrinsic to the spice. A tonka bean’s only kitchen purpose is to introduce that flavor compound deliberately, so it falls on the wrong side of the line. European regulators landed elsewhere, setting limits (commonly 2–25 mg/kg depending on the food) rather than a blanket prohibition.

Culinary and food-science view. Outside the US, tonka is an openly prized ingredient. Chefs in France, Canada, and across Europe use it in custards, chocolate, and syrups for its vanilla-almond-clove complexity. The McGill University Office for Science and Society has noted that even Michelin-starred US kitchens have quietly sourced it for years despite the ban — a sign that working food professionals regard culinary-dose tonka as a flavor tool, not a hazard, and treat the prohibition as out of step with practice elsewhere.

Public and consumer angle. For most people the practical risk isn’t tonka at all — it’s not knowing which cinnamon they’re buying. Ceylon (“true”) cinnamon contains only trace coumarin (around 0.004%), while cassia can be 200-plus times higher, and the two are nearly indistinguishable as powders. The other real-world exposure route is unregulated imported “vanilla” from tourist markets, which is sometimes bulked out with tonka or synthetic coumarin in place of real vanilla. Those are the scenarios where coumarin intake can quietly climb — not a once-a-year tonka dessert.

Where Does the Evidence End and Regulatory Inertia Begin?

The three views actually converge more than they conflict. Everyone agrees coumarin is hepatotoxic at high, sustained doses and that a small subgroup is more vulnerable. Where they diverge is on whether a flavoring-level dose justifies an absolute ban. The European model — a TDI plus food-specific limits — reflects the human data: realistic culinary exposure sits well under the threshold, and the people who actually developed liver injury were taking coumarin as medicine in gram-scale doses.

The US ban predates that human evidence by decades. It was built on 1950s rodent studies and the era’s precautionary reflex, and it has never been revisited, partly because there’s little commercial pressure to do so — tonka is a niche ingredient, and the FDA has bigger priorities. So the ban persists less because the science demands it and more because nothing has forced a re-examination. That’s not the same as saying coumarin is harmless: the susceptible-subgroup finding is a genuine open question, and “we don’t know who’s vulnerable or why” is a real argument for caution. But it’s caution that European regulators have managed with limits rather than prohibition.

What Comes Next?

The most useful open questions are about the susceptible subgroup. Identifying the genetic or metabolic markers (CYP2A6 status is one candidate) that predict who handles coumarin poorly could turn a blanket rule into targeted guidance. Pharmacogenomic screening, better population-level exposure data that separates cassia from Ceylon cinnamon, and clearer labeling of cinnamon type would all do more for public health than the tonka ban does. Whether the FDA ever revisits a 70-year-old order for a niche ingredient is, realistically, the least likely development of the three.

What Is the Tonka Bean’s LyfeiQ?

Credibility Rating: 7/10

• Scientific Rigor: 7/10 — Solid animal toxicology and a growing body of human metabolic data; the susceptible-subgroup mechanism remains unresolved.
• Real-World Risk at Food Doses: 8/10 favorable — Culinary exposure falls far below the TDI; cinnamon is a bigger everyday source.
• Regulatory Coherence: 4/10 — The US blanket ban is hard to reconcile with the human evidence and Europe’s limit-based approach.
• Risk-Benefit Ratio: Favorable — At culinary doses the flavor payoff comes with negligible risk for most people.
• Expert Consensus: Coumarin is hepatotoxic at high doses; mainstream toxicology supports limits, and many scientists view the US total ban as disproportionate.

👉 Who should try this: Adventurous cooks outside the US (where it’s legal), and anyone curious about the vanilla-almond flavor — used sparingly, as intended.

👉 Who should skip this: People with significant liver disease, anyone consuming large daily amounts of cassia cinnamon already, and — legally — US commercial food sellers, for whom it remains prohibited.

⚕️ LyfeiQ Score: 6/10 — If you’re somewhere it’s legal, a light grating of tonka is a flavor worth knowing and not worth fearing. Watch your cinnamon type more than your tonka, and steer clear of sketchy imported “vanilla.”

Citations

1. Abraham K, et al. Toxicology and risk assessment of coumarin: focus on human data. Molecular Nutrition & Food Research, 2010. doi.org
2. Abraham K, et al. Relative bioavailability of coumarin from cinnamon and cinnamon-containing foods compared to isolated coumarin: a four-way crossover study in human volunteers. Molecular Nutrition & Food Research, 2010. doi.org
3. Uehara T, et al. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans. Human & Experimental Toxicology, 2008. doi.org
4. Farinola N, Piller NB. CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients? Pharmacogenomics, 2007. doi.org
5. US FDA. 21 CFR 189.130 — Coumarin. Code of Federal Regulations. ecfr.gov
6. McGill University Office for Science and Society. Coumarin, the illegal chemical causing Americans to miss out on a sweet treat. mcgill.ca

Disclaimer: This content includes personal opinions and interpretations based on available sources and should not replace medical advice. This content includes interpretation of available research and should not replace medical advice. Although the data found in this blog and infographic has been produced and processed from sources believed to be reliable, no warranty expressed or implied can be made regarding the accuracy, completeness, legality or reliability of any such information. This disclaimer applies to any uses of the information whether isolated or aggregate uses thereof.